EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Development of a low allergenic product for patients with milk allergy and assessment of its specific IgE reactivity

Duygu Yazici iD, Hande Suer iD, Cemre Naz Bulbuloglu iD, Elif Guzar iD, Engin Koçak iD, Emirhan Nemutlu iD, Betul Buyuktiryaki iD, Cansin Sackesen iD

Pediatric Allergy and Immunology · 2024

DOI: 10.1111/pai.14174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, 2024. Verfasst von Duygu Yazici und 7 weiteren Autor:innen. Beteiligte Einrichtung: Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland. Hauptthemen laut MEDLINE: Immunoglobulin E, Milk Hypersensitivity, Enzyme-Linked Immunosorbent Assay, Allergens. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Türkiye Sağlık Enstitüleri Başkanlığı, Koç Üniversitesi Translasyonel Tıp Araştırma Merkezi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Milk oral immunotherapy is the riskiest and most unpredictable form of oral immunotherapy. We aimed to produce a low allergenic product than conventional once baked‐cake/muffin, to develop indirect in‐house ELISA to check the tolerance status with milk products and evaluate IgE reactivity of patients' sera via western blotting (WB) and indirect in‐house ELISA.

Method

A low allergenic product named biscotti‐twice baked‐cake was developed, and the total protein concentration was determined. The protein content was studied by SDS‐PAGE and proteomics. Milk‐specific IgE (sIgE) binding assays were performed by WB and indirect in‐house ELISA by using patients' sera.

Results

Casein band intensity was observed to be lower in the biscotti‐twice baked‐cake than in the once baked‐cake ( p = .014). Proteomics analysis and αS1‐casein measurement showed that the lowest intensity of casein was found in biscotti. The low binding capacity of milk sIgE to biscotti compared with once baked‐cake was shown by WB ( p = .0012) and by indirect in‐house ELISA ( p = .0001). In the ROC analysis, the area under the curve (AUC) of the in‐house ELISA IgE was comparable with Uni‐CAP milk and casein sIgE. The AUC of the in‐house ELISA IgE for cake (0.96) and biscotti (1) was slightly better than Uni‐CAP milk sIgE (0.94; 0.97) and casein sIgE (0.96; 0.97), respectively.

Conclusion

The low allergenicity of the newly developed low allergenic product “biscotti‐twice baked‐cake” has been demonstrated by in vitro experiments. Biscotti could be a safe treatment option than once baked‐cake/muffin in patients who are reactive to once baked‐milk products.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin EMilk HypersensitivityEnzyme-Linked Immunosorbent AssayAllergensDesensitization, ImmunologicHumansFemaleMaleChild, PreschoolChildAnimalsMilkInfantCaseinsProteomicsBlotting, WesternAdministration, OralAdolescent

Stichwörter der Autor:innen

ELISAIgE reactivitybaked milkcaseincow's milk allergyfood allergyimmunotherapylow allergenic food productproteomics

Substanzen

Immunoglobulin EAllergensCaseins

Autor:innen und Institutionen

  • Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
  • Research Center for Translational Medicine (KUTTAM), Koç University School of Medicine, Istanbul, Turkey.
  • Graduate School of Health Sciences, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
  • Department of Analytical Chemistry, Faculty of Gulhane Pharmacy, Health Sciences University, Ankara, Turkey.
  • Department of Analytical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.
  • Division of Pediatric Allergy, School of Medicine, Koc University, Istanbul, Turkey.

ORCID-Profile: Duygu Yazici, Hande Suer, Cemre Naz Bulbuloglu, Elif Guzar, Engin Koçak, Emirhan Nemutlu, Betul Buyuktiryaki, Cansin Sackesen

Förderung

  • Türkiye Sağlık Enstitüleri Başkanlığı
  • Koç Üniversitesi Translasyonel Tıp Araştırma Merkezi

Zitieren

APA

Yazici, D., Suer, H., Bulbuloglu, C. N., Guzar, E., Koçak, E., Nemutlu, E., Buyuktiryaki, B., & Sackesen, C. (2024). Development of a low allergenic product for patients with milk allergy and assessment of its specific IgE reactivity. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.14174

Vancouver

Yazici D, Suer H, Bulbuloglu CN, Guzar E, Koçak E, Nemutlu E, et al. Development of a low allergenic product for patients with milk allergy and assessment of its specific IgE reactivity. Pediatric Allergy and Immunology. 2024. doi:10.1111/pai.14174

BibTeX
@article{Yazici2024,
  author = {Yazici, Duygu and Suer, Hande and Bulbuloglu, Cemre Naz and Guzar, Elif and Koçak, Engin and Nemutlu, Emirhan and Buyuktiryaki, Betul and Sackesen, Cansin},
  title = {Development of a low allergenic product for patients with milk allergy and assessment of its specific IgE reactivity},
  journal = {Pediatric Allergy and Immunology},
  year = {2024},
  doi = {10.1111/pai.14174}
}
Kostenlos starten →